Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

Cited In for PubMed (Select 20592239)

1.

Antibiotics in ingested human blood affect the mosquito microbiota and capacity to transmit malaria.

Gendrin M, Rodgers FH, Yerbanga RS, Ouédraogo JB, Basáñez MG, Cohuet A, Christophides GK.

Nat Commun. 2015 Jan 6;6:5921. doi: 10.1038/ncomms6921.

2.

Potential involvement of Brugia malayi cysteine proteases in the maintenance of the endosymbiotic relationship with Wolbachia.

Lustigman S, Melnikow E, Anand SB, Contreras A, Nandi V, Liu J, Bell A, Unnasch TR, Rogers MB, Ghedin E.

Int J Parasitol Drugs Drug Resist. 2014 Aug 26;4(3):267-77. doi: 10.1016/j.ijpddr.2014.08.001. eCollection 2014 Dec.

3.

Minocycline protects against hepatic ischemia/reperfusion injury in a rat model.

Li Y, Li T, Qi H, Yuan F.

Biomed Rep. 2015 Jan;3(1):19-24. Epub 2014 Nov 11.

4.

Myocardial matrix metalloproteinase-2: inside out and upside down.

DeCoux A, Lindsey ML, Villarreal F, Garcia RA, Schulz R.

J Mol Cell Cardiol. 2014 Dec;77:64-72. doi: 10.1016/j.yjmcc.2014.09.016. Epub 2014 Sep 28.

PMID:
25261607
5.

Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors.

Roy DM, Walsh LA.

Breast Cancer (Dove Med Press). 2014 Jul 3;6:81-91. doi: 10.2147/BCTT.S46020. eCollection 2014. Review.

6.
7.

Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications.

Hua Y, Nair S.

Biochim Biophys Acta. 2015 Feb;1852(2):195-208. doi: 10.1016/j.bbadis.2014.04.032. Epub 2014 May 9. Review.

PMID:
24815358
8.

Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors.

Spinale FG, Villarreal F.

Biochem Pharmacol. 2014 Jul 1;90(1):7-15. doi: 10.1016/j.bcp.2014.04.011. Epub 2014 Apr 26. Review.

PMID:
24780447
9.

Skin hypersensitivity to sun light due to doxycycline ingestion causing hand partial-thickness burn.

Simman R, Raynolds D.

J Am Coll Clin Wound Spec. 2013 Feb 8;4(1):16-7. doi: 10.1016/j.jccw.2013.01.005. eCollection 2012 Mar.

10.

Interplay between three RND efflux pumps in doxycycline-selected strains of Burkholderia thailandensis.

Biot FV, Lopez MM, Poyot T, Neulat-Ripoll F, Lignon S, Caclard A, Thibault FM, Peinnequin A, Pagès JM, Valade E.

PLoS One. 2013 Dec 27;8(12):e84068. doi: 10.1371/journal.pone.0084068. eCollection 2013.

11.

Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury.

Abcouwer SF, Lin CM, Shanmugam S, Muthusamy A, Barber AJ, Antonetti DA.

J Neuroinflammation. 2013 Dec 10;10:149. doi: 10.1186/1742-2094-10-149.

12.

Integrated transcriptomic and proteomic analysis of the global response of Wolbachia to doxycycline-induced stress.

Darby AC, Gill AC, Armstrong SD, Hartley CS, Xia D, Wastling JM, Makepeace BL.

ISME J. 2014 Apr;8(4):925-37. doi: 10.1038/ismej.2013.192. Epub 2013 Oct 24.

14.

MMP-9 and CXCL8/IL-8 are potential therapeutic targets in epidermolysis bullosa simplex.

Lettner T, Lang R, Klausegger A, Hainzl S, Bauer JW, Wally V.

PLoS One. 2013 Jul 19;8(7):e70123. doi: 10.1371/journal.pone.0070123. Print 2013.

15.

Minocycline: far beyond an antibiotic.

Garrido-Mesa N, Zarzuelo A, Gálvez J.

Br J Pharmacol. 2013 May;169(2):337-52. doi: 10.1111/bph.12139. Review.

16.

Potential for enhanced therapeutic activity of biological cancer therapies with doxycycline combination.

Tang H, Sampath P, Yan X, Thorne SH.

Gene Ther. 2013 Jul;20(7):770-8. doi: 10.1038/gt.2012.96. Epub 2013 Jan 3.

17.

Does inhibiting Sur1 complement rt-PA in cerebral ischemia?

Simard JM, Geng Z, Silver FL, Sheth KN, Kimberly WT, Stern BJ, Colucci M, Gerzanich V.

Ann N Y Acad Sci. 2012 Sep;1268:95-107. doi: 10.1111/j.1749-6632.2012.06705.x. Review.

18.

Matrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome.

Siller SS, Broadie K.

Neural Plast. 2012;2012:124548. doi: 10.1155/2012/124548. Epub 2012 May 20. Review.

19.

Disruption of the serotonergic system after neonatal hypoxia-ischemia in a rodent model.

Buller KM, Wixey JA, Reinebrant HE.

Neurol Res Int. 2012;2012:650382. doi: 10.1155/2012/650382. Epub 2012 Feb 8.

20.

Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer's disease-like amyloid pathology.

Ferretti MT, Allard S, Partridge V, Ducatenzeiler A, Cuello AC.

J Neuroinflammation. 2012 Apr 2;9:62. doi: 10.1186/1742-2094-9-62.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk